Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	rhEPO-Naive GSK1278863	136
Overall Study	STARTED	rhEPO-Naive Control	44
Overall Study	STARTED	rhEPO-User GSK1278863	36
Overall Study	STARTED	rhEPO-User Control	36
Overall Study	COMPLETED	rhEPO-Naive GSK1278863	116
Overall Study	COMPLETED	rhEPO-Naive Control	41
Overall Study	COMPLETED	rhEPO-User GSK1278863	32
Overall Study	COMPLETED	rhEPO-User Control	33
Overall Study	NOT COMPLETED	rhEPO-Naive GSK1278863	20
Overall Study	NOT COMPLETED	rhEPO-Naive Control	3
Overall Study	NOT COMPLETED	rhEPO-User GSK1278863	4
Overall Study	NOT COMPLETED	rhEPO-User Control	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01977573/flow